Women treated with hormones during menopause do not face a higher risk of dying from cancer or cardiovascular diseases than non-users. This is the...
Vous n'êtes pas connecté
Maroc - MEDINDIA.NET - Medindia Health News - 01/Feb 15:46
In postmenopausal women, combining menopausal hormone therapy with tirzepatide resulted in markedly greater weight loss than tirzepatide alone.
Women treated with hormones during menopause do not face a higher risk of dying from cancer or cardiovascular diseases than non-users. This is the...
Women treated with hormones during menopause do not face a higher risk of dying from cancer or cardiovascular diseases than non-users. This is the...
As dementia and other neurodegenerative diseases become more common worldwide, researchers are searching urgently for ways to protect the brain as we...
THURSDAY, Feb. 12, 2026 -- Initiation of hormone therapy (HT) after age 65 years is tied to significantly increased risks for cancer and vascular...
THURSDAY, Feb. 12, 2026 -- Initiation of hormone therapy (HT) after age 65 years is tied to significantly increased risks for cancer and vascular...
Women who experienced challenges during the menopause set up businesses to help others. ......
Women who experienced challenges during the menopause set up businesses to help others. ......
A widely used diabetes and weight loss medication may do more than lower blood sugar and help people shed pounds. New research suggests that...
Audience: Health Care Professional, Consumer February 12, 2026 -- The U.S. Food and Drug Administration has approved drug labeling changes to six...
Audience: Health Care Professional, Consumer February 12, 2026 -- The U.S. Food and Drug Administration has approved drug labeling changes to six...